Noncompliance with Medical Treatment: Pseudomalabsorption of Levothyroxine

Mohsen S. Eledrisi, Aleksandra Szymajda, Mohammad Alshanti, Randall J. Urban

Research output: Contribution to journalArticlepeer-review

22 Scopus citations


Euthyroidism could not be achieved in a 41-year-old woman with primary hypothyroidism despite escalating doses of oral levothyroxine as high as 600 μg and 100 μg of triiodothyronine daily. Clinical and biochemical evidence of hypothyroidism persisted even with the administration of intramuscular levothyroxine. There was no history compatible with drug-induced malabsorption of levothyroxine. Evaluation of serum showed no thyroid hormone autoantibodies. After hospitalization, intravenous levothyroxine therapy returned thyroid hormone to normal concentrations. Moreover, thyroid hormone loading tests revealed normal oral absorption of both levothyroxine and triiodothyronine. Noncompliance with medical treatment leading to pseudomalabsorption of levothyroxine should be considered in patients who have persistent hypothyroidism with high-dose replacement therapy.

Original languageEnglish (US)
Pages (from-to)833-836
Number of pages4
JournalSouthern medical journal
Issue number1-10
StatePublished - Aug 2001

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Noncompliance with Medical Treatment: Pseudomalabsorption of Levothyroxine'. Together they form a unique fingerprint.

Cite this